このエントリーをはてなブックマークに追加
ID 62226
JaLCDOI
FullText URL
75_3_315.pdf 1.99 MB
Author
Wada, Riho Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fujiwara, Masaki Department of Neuropsychiatry, Okayama University Hospital
Yamada, Yuto Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nakaya, Naoki Department of Health Sciences, Saitama Prefectural University
Fujimori, Maiko Division of Health Care Research, Behavioral Sciences and Survivorship Research Group, National Cancer Center
So, Ryuhei Okayama Psychiatric Medical Center
Kodama, Masafumi Okayama Psychiatric Medical Center
Higuchi, Yuji Care of Your Mind, Taiyo Hills Hospital
Kakeda, Kyoko Department of Neuropsychiatry, Kochi Medical School, Kochi University
Uchitomi, Yosuke Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital
Yamada, Norihito Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Inagaki, Masatoshi Department of Psychiatry, Faculty of Medicine, Shimane University
Abstract
It is necessary to assess functional impairment when treating schizophrenia. The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) has been adopted as a measure of functional disability in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This study was a secondary analysis from a cross-sectional study of health-related behaviors among patients with schizophrenia. We examined the validity and reliability of the Japanese version of the 12-item WHODAS 2.0 when self-administered by such patients. Participants were 350 outpatients with schizophrenia from a psychiatric hospital. The standard six-factor structure of the WHODAS 2.0 showed a good fit for these participants. The Cronbach’s alpha coefficient was 0.858, showing good internal consistency. The WHODAS 2.0 showed moderate correlations with the modified Global Assessment of Functioning and Kessler 6 scales (r=−0.434 and 0.555, respectively). The results of this study show that the Japanese version of the 12-item self-administered WHODAS 2.0 has good internal consistency and convergent validity among patients with schizophrenia. Further exploration of the usefulness of WHODAS 2.0 in clinical settings is needed.
Keywords
disability
schizophrenia
validity
reliability
WHODAS 2.0
Amo Type
Original Article
Publication Title
Acta Medica Okayama
Published Date
2021-06
Volume
volume75
Issue
issue3
Publisher
Okayama University Medical School
Start Page
315
End Page
322
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
English
Copyright Holders
CopyrightⒸ 2021 by Okayama University Medical School
File Version
publisher
Refereed
True
PubMed ID
NAID